The Valley Desk

NCT07125079 · Observational study

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

Overall registry status Recruiting

Conditions ARDS (Acute Respiratory Distress Syndrome)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov